The medical treatment of Parkinson’s disease should begin when the functional disability starts appearing. According to a study, Levodopa is unlikely to affect the progression of Parkinson’s disease in the first-year-and-a-half following diagnosis.
Symptoms bettered to a certain extent by 80 weeks, and side effects were similar, indicating people should start treatment early as needed for symptomatic relief.